-
Rail journey offers a slower route to a Berlin city break
-
Energy bill plan could use HMRC income data to target support
-
Arsenal control title race as Manchester United fall into bottom three
-
Business owner earning £6,000 a month tackles £70,000 debt
-
Suspected Krakow gunman dies after attack that killed six
-
Nvidia chief faces inquiry after disclosing affair with suspected Chinese agent
-
Carrick backs Dalot after hostile reception from Manchester United fans
-
Comet returns as online electrical marketplace 14 years after collapse
-
Fire in Northern China Apartment Building Kills 14
-
Solihull Hospital Performs First Robotic-Assisted Gynaecological Cancer Surgeries
-
Apple’s 20th Anniversary iPhone to Skip Action Button for Camera Control Integration
-
Nvidia CEO Jensen Huang Admits Infidelity Amid Spy Investigation
-
Family of Woman Who Died at Voting Station Condemns Official Silence
-
Ted Scheinman’s Journey Through Depression and Electroconvulsive Therapy
-
Karen Wazen Launches First Standalone Boutiques in Cairo
-
Phoenix Symphony Resumes Performances Amid Financial Uncertainty
-
New 401k Gold IRA Investment Guide Explains the Best Way to Invest in Gold for Retirement (2026 Update)
-
Making Your Home Safer for Aging Parents: Accessibility Renovations That Add Value
-
InterContinental Hotels Group PLC Announces Transaction in Own Shares - November 09
-
DataMEDS AI Announces Corexa Pharmacy's First Commercial Sale of Compounded Peptides Under FDA Enforcement Discretion Policy
-
Opti Digital Launches NEXA, an AI-Powered Intelligence Layer
-
Pace Launches Three-Business-Day Culture-Based 'L. pneumophila' Testing
-
Tintina Mines Intersects 460m at 0.50% CuEq at the Dos Amigos Copper-Gold Project in Chile
-
Hillcrest and Equipmake Sign Definitive Agreement to Jointly Develop and License ZVS Inverter Technology for Heavy-Duty Electric Vehicles
-
HyProMag USA Advances North Texas Rare Earth Magnet Facility With First Major Equipment Delivery
-
United States Antimony Corporation Announces Webcast Time set for Thursday, November 12, 2026 at 4:15 PM ET to Report on Third Quarter and Nine Months Ended September 30, 2026 Financial and Operating Results
-
Ispire Technology Inc. Reports First Quarter Fiscal Year 2027 Financial Results
-
Silver Storm Reports Concentrate Deliveries from La Parrilla
-
CoTec Holdings Corp. Notes HyProMag USA Advances North Texas Rare Earth Magnet Facility With First Major Equipment Delivery
-
Nextech3D.ai Closes $720,000 Management-Led Private Placement
-
Medicus Pharma to Highlight Rationale for CD228V Co-Development and License Agreement
-
Gabriel Provides Corporate Update
-
SMX Is Building a Verifiable Identity Layer for Fashion, From Cotton Fields to Luxury Resale
-
Gladstone Land Corporation Earnings Call and Webcast Information
-
The Metals Royalty Company to Host Corporate Update Webinar on November 16, 2026
-
Aptevo Presents Preclinical Data at SITC 2026 Showing Potential to Overcome Immune Suppression in Solid Tumors
-
Eylsia Nicolas Launches Global "Wake Me Up" Franchise After Surpassing 100 Million Meta Views in One Week
-
BioLargo Targets Growing Industrial PFAS Market with MasterClass at International Water Conference
-
Hancock Health Expands Robot Specimen Delivery to Parkway Building, Adding Scheduled and On-Demand Runs to the Lab
-
Jericho Energy Ventures to Participate in Cantor Convergence 4th Annual Crypto and AI Infrastructure Conference
-
IGC Pharma Reports Third Quarter 2026 Financial Results and Provides Business Update
-
Tectonic Metals Adds Mine Development and Alaska Native Partnership Leaders Ahead of 2027 Mineral Resource Estimate and Preliminary Economic Assessment
-
Ai4 Celebrates Successful Debut of Applied AI Research Conference (AAIRC), Bridging Academic Research and Industry Innovation
-
Releaf Unveils UK-first THCV for Weight Management
-
AsiaFIN's Insite MY Holdings and MENA Insite MY Sign Distributorship Agreement and Announce Second Bank Customer in Saudi Arabia
-
Top Chef Winner Nicole Gomes Opens Lucky Lily Asian Brasserie at YVR
-
First Drive: 2027 BMW i760 xDrive Review
-
Marc Almond to Close Soft Cell Era After Final 'Danceteria' Tour
-
Gary, Indiana Blackout Exposes FEMA Relief Disparities Along Racial Lines
-
Malta Chamber of Commerce and FIMBank Sign Alliance Agreement to Boost Corporate Finance
Doctor who provided Matthew Perry's drugs pleads guilty
One of two doctors charged in connection with the drug overdose death of "Friends" star Matthew Perry pleaded guilty in a US court on Wednesday.
Mark Chavez, 54, faces up to 10 years in prison after admitting to conspiring to distribute ketamine in the weeks before the actor was found dead in the pool of his Los Angeles home.
Appearing before US District Judge Sherilyn Peace Garnett in a Los Angeles court, the bespectacled Chavez answered a series of questions before entering his plea of "Guilty, your honor."
Perry's lengthy struggles with substance addiction were well-documented, but his death in October 2023 sent shockwaves through the global legions of "Friends" fans.
A criminal investigation was launched soon after an autopsy discovered the actor had high levels of ketamine -- an anesthetic -- in his system.
Two others caught in the dragnet -- a live-in assistant and an acquaintance -- have already pleaded guilty to their charges.
Another doctor -- Salvador Plasencia -- allegedly bought ketamine off Chavez and sold it to the desperate star at hugely inflated prices, musing "I wonder how much this moron will pay."
Jasveen Sangha, the alleged "Ketamine Queen" who supplied drugs to high-end clients and celebrities, is charged with selling Perry the dose that killed him.
Both Plasencia and Sangha face one count of conspiracy to distribute ketamine, as well as a raft of other charges, which they have denied.
Their trials have been set for March, and both face lengthy prison terms if found guilty.
Chavez admitted in his plea agreement to selling ketamine to Plasencia, including doses that he had diverted from his former ketamine clinic.
He was released on $50,000 bail on Wednesday and ordered not to practice medicine. He is expected to be sentenced in April.
Perry played Chandler Bing on the hit TV sitcom from 1994 to 2004 and talked openly of his decades-long battles with addiction.
He had been taking ketamine, a controlled drug, as part of supervised therapy.
Doctors and veterinarians use ketamine as an anesthetic, and researchers have explored its use as a treatment for depression.
Underground users take it for its hallucinogenic effects, though it can be addictive and dangerous for people with underlying health problems.
"Friends," which followed the lives of six New Yorkers navigating adulthood, dating and careers, drew a massive global following and made megastars of previously unknown actors.
Perry's role as the sarcastic man-child Chandler brought him fabulous wealth, but hid a dark struggle with addiction to painkillers and alcohol.
In 2018, he suffered a drug-related burst colon and underwent multiple surgeries.
In his 2022 memoir "Friends, Lovers and the Big Terrible Thing," Perry described going through detox dozens of times.
"I have mostly been sober since 2001," he wrote, "save for about sixty or seventy little mishaps."
M.Robinson--AT